The proposed intervention is active in the field of research and development (R & S) relating to the health industry. IN PARTICULAR, THE OBJECTIVE OF THE PROJECT IS THE DISCOVERY OF INNOVATIVE DRUGS FOR THE TREATMENT OF ELERATITE B (TRL 3: EXPERIMENTAL TEST OF THE PRECLINICAL CONCEPT). HEPATITIS B IS AN INFLAMMATORY DISEASE OF THE LIVER CAUSED BY HBV VIRUS. 5 % OF ADULTS AND > 50 % OF CHILDREN UNDER 5 YEARS INFECTED BY HBV HAVE BECOME CHRONICALLY ILL PEOPLE AT HIGH RISK OF DEVELOPING C